20950 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
MICRONIZED COMPOSITIONS FOR WOUND HEALING PREPARED FROM INTACT HUMAN AMNION-CHORION TISSUE HAVING AN INTACT INTERMEDIATE SPONGY LAYER POSITIONED THERE BETWEEN
#2AAV VECTOR OPTIMIZED FOR INTRATHECAL ADMINISTRATION INTO WHICH HEPATOCYTE GROWTH FACTOR GENE IS INTRODUCED
#3SPINAL CORD INJURY THERAPEUTIC TARGETING FROM ACUTE PHASE TO SUBACUTE PHASE
#4ALLOGENEIC HUMAN PLASMA AND PLATELET DERIVED PRODUCTS AND USES THEREOF
#5PROCESSES FOR MAKING AND USING A MESENCHYME STEM CELL SECRETOME FOR LIMBAL STEM CELL DEFICIENCY (LSCD) TREATMENT
#6MICRONIZED COMPOSITIONS FOR WOUND HEALING PREPARED FROM INTACT HUMAN AMNION-CHORION TISSUE HAVING AN INTACT INTERMEDIATE SPONGY LAYER POSITIONED THERE BETWEEN
#7PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITION
#8GROWTH FACTOR LOADED NANOFIBERS AND METHODS OF USE THEREOF
#9HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE
#10THERAPEUTIC AGENT FOR SPINAL CORD INJURY
#11NOVEL THERAPEUTIC COMPRISING A SECRETOME FROM MESENCHYMAL STEM CELLS OF UMBILICORD TISSUE OR WHARTON'S JELLY
#12CARDIAC STEM CELLS FOR CARDIAC REPAIR
#13PREPARATION METHOD OF PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC STROKE
#14ADHESIVE CELL TISSUE GELS
#15HYDROGEL COMPOSITION, METHOD FOR PRODUCING THE SAME, AND USE THEREOF FOR STEM CELL MIMETIC PEPTIDE SUPPLEMENTATION
#16BIOACTIVE GRANULAR HYDROGEL SCAFFOLDS AND USE THEREOF
#17LYMPHANGIOGENESIS-PROMOTING AGENTS
#18TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS
#19CARDIAC STEM CELLS FOR CARDIAC REPAIR
#20Methods for Treating and Diagnosing Risk of Renal Allograft Fibrosis and Rejection
#21Systems and Methods for Angiogenic Treatment in Wound Healing
#22HUMAN UMBILICAL COMPOSITIONS AND METHODS FOR DERMAL APPLICATION
#23METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SPINAL CORD INJURY
#24CARDIAC STEM CELLS FOR CARDIAC REPAIR
#25Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of ANG, ANGPT1, VEGFA, FGF1, HIF1a, HGF, SDF1, KLK4, PDGFC, PROK1, and PROK2 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-ANG, or Escherichia coli strain SCS110-AF/VTvaf17-ANGPT1, or Escherichia coli strain SCS110-AF/VTvaf17-VEGFA, or Escherichia coli strain SCS110-AF/VTvaf17-FGF
#26Micronized compositions for wound healing prepared from intact human amnion-chorion tissue having an intact intermediate spongy layer positioned there between
#27HB-EGF GENE THERAPY FOR DIABETES
#28COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORNEAL HAZE AND SCARRING
#29Cardiac stem cells for cardiac repair
#30PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOME
#31METHODS AND ASSAYS FOR SECRETOME ACTIVITY ANALYSIS
#32Cardiac stem cells for cardiac repair
#33LOW-DOSE HEPATOCYTE GROWTH FACTOR GENE THERAPY FOR DIABETES
#34Methods for treating an ocular condition with cellular fibronectin compositions
#35COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT
#36STEM CELL CONDITIONED MEDIA FOR CLINICAL AND COSMETIC APPLICATIONS
#37Use of Cell-Free Fat Extract for Treating Osteoporosis
#38Cardiac stem cells for cardiac repair
#39EFFECTS OF CELL-FREE FAT LIQUID EXTRACT ON MACROPHAGE POLARIZATION MODULATION AND DISEASE TREATMENT
#40RNA FOR TREATMENT OR PROPHYLAXIS OF A LIVER DISEASE
#41COMPOSITION AND USE THEREOF
#42MEDICAMENT COMPRISING A COMBINATION OF AMNIOTIC MEMBRANE AND UMBILICAL CORD BLOOD SERUM FOR WOUND HEALING
#43COMPOSITIONS OF GROWTH FACTOR FOR THE TREATMENT OF EYE DISEASE
#44Cellular fibronectin compositions
#45Processes for making a cellular fibronectin composition
#46MESENCHYMAL STEM CELL EXPRESSING HEPATOCYTE GROWTH FACTOR, AND USE THEREOF
#47HUMAN UMBILICAL CORD COMPOSITIONS AND METHODS FOR INTRA-ARTICULAR THERAPY
#48TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
#49TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
#50COMPOSITIONS FOR TREATMENT OF AZOOSPERMIA, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOF
#51METHODS OF OCULAR TREATMENT USING AN ENGINEERED DIMERIC FRAGMENT OF HEPATOCYTE GROWTH FACTOR
#52TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS
#53ENZYME-DEGRADABLE HYDROGEL FOR DELIVERY OF A PAYLOAD
#54POLYETHYLENE GLYCOL-MODIFIED FORM OF HEPATOCYTE GROWTH FACTOR OR ACTIVE FRAGMENT THEREOF
#55LYMPHANGIOGENESIS-PROMOTING AGENTS
#56COMPOSITIONS FOR PROMOTING SKIN REGENERATION, SKIN REJUVENATION, AND WOUND HEALING AND METHODS FOR PREPARATION AND USE THEREOF
#57ENGINEERED FIBROBLAST GROWTH FACTOR VARIANTS COMBINED WITH ENGINEERED HEPATOCYTE GROWTH FACTOR VARIANTS FOR TREATMENT
#58Compositions and methods for prevention and treatment of corneal haze and scarring
#59COMPOSITION FOR PREVENTING OR TREATING PULMONARY FIBROSIS CONTAINING EXOSOME ISOLATED FROM ADIPOSE-DERIVED STEM CELL AS ACTIVE INGREDIENT
#60Cardiac stem cells for cardiac repair
#61Processes for making and using a mesenchymal stem cell derived secretome
#62Composition for increasing the expression of a growth factor gene, comprising coreshell structured microparticles as active ingredient
#63Processes for making and using a mesenchymal stem cell derived secretome
#64SKIN OINTMENT FOR TREATING LABIA MINORA SKIN
#65Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
#66Adeno-associated virus vector
#67GENE THERAPY FOR DIABETIC NEUROPATHY USING AN HGF ISOFORM
#68Adeno-associated virus virion for gene transfer to nervous system cells
#69Processes for making and using a mesenchymal stem cell derived secretome
#70Visible light-curable water-soluble chitosan derivative, chitosan hydrogel, and preparation method therefor
#71Systems and methods for angiogenic treatment in wound healing
#72Compositions and methods for improving cardiac function
#73Method for inducing production of vascular endothelial growth factor
#74THERAPEUTIC AGENT FOR DILATED CARDIOMYOPATHY
#75COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORNEAL HAZE AND SCARRING
#76Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction
#77Treatment of collagen defects using protein solutions
#78COMPOSITION FOR PREVENTING OR TREATING LIVER FIBROSIS OR CIRRHOSIS, COMPRISING EXPRESSION OR ACTIVITY ENHANCER OF TIF1y AS ACTIVE INGREDIENT
#79COMPOSITIONS AND METHODS FOR TREATING AND REPAIRING TENDONS
#80TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
#81Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides
#82RNA for treatment or prophylaxis of a liver disease
#83LYMPHANGIOGENESIS-PROMOTING AGENTS
#84Gene therapy for diabetic neuropathy using an HGF isoform
#85Compositions and methods for vascular protection against reperfusion injury after myocardial ischemia
#86Drug composition for angiogenesis therapy
#87METHOD TO IMPROVE THE EFFECTIVENESS OF ANTI-CANCER THERAPIES BY EXPOSING CANCER CELLS TO AN INFLAMMATORY STIMULUS PRIOR TO TREATMENT
#88USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME
#89Noxipoints stimulating devices using light, mechanical force, or heat as a source of stimulation
#90Postpartum cells derived from placental tissue, and methods of making and using the same
#91Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
#92CELLULARIZED HYDROGELS AND METHODS OF USING THE SAME
#93HGF preparation suitable for treatment of neurological disorders
#94Adhesive cell tissue gels
#95PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC STROKE AND METHOD THEREOF
#96MESENCHYMAL STEM CELL EXPRESSING HEPATOCYTE GROWTH FACTOR, AND USE THEREOF
#97Soft tissue repair and regeneration using postpartum-derived cells and cell products
#98Composition for treatment of damaged part
#99Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
#100Compositions and methods for prevention and treatment of corneal haze and scarring
#101Compositions and methods for cardiac tissue repair
#102GENE THERAPY FOR DIABETIC NEUROPATHY USING AN HGF ISOFORM
#103Composition For Targeted Delivery Of Nucleic Acid-Based Therapeutics
#104Cardiac stem cells for cardiac repair
#105Wearable noxipoints stimulating devices
#106MULTIMERIC COMPOUNDS OF A KRINGLE DOMAIN FROM THE HEPATOCYTE GROWTH FACTOR / SCATTER FACTOR (HGF/SF)
#107MET receptor agonist proteins
#108Immortalized stem cell, compositions, preparations and uses thereof
#109HGF preparation suitable for treatment of neurological disorders
#110Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#111Method for treating peripheral vascular disease using hepatocyte growth factor and stromal cell derived factor 1A
#112Methods of and devices for chemical and threshold-gated electrical neuro-immuno-stimulation
#113Postpartum cells derived from placental tissue, and methods of making and using the same
#114Method of Preventing and Treating Retinal Microvasculature Inflammation Using C-Met Signaling Pathway Inhibition
#115Pharmaceutical composition for treating and/or preventing esophageal stenosis
#116Cell sheet composition for inhibiting progression of renal disorder, method of producing the same, and method of inhibiting progression of renal disorder using the same
#117Lyophilized formulation of HGF
#118Conditioned medium of liver progenitor cells
#119Postpartum cells derived from placental tissue, and methods of making and using the same
#120Postpartum cells derived from placental tissue, and methods of making and using the same
#121Method of preparing a growth factor concentrate
#122Soft tissue repair and regeneration using postpartum-derived cells and cell products
#123Methods of treating amyotrophic lateral sclerosis by HGF
#124Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
#125Generating hepatocytes
#126Preparations containing hepatocyte growth factor and hyaluronic acid, and methods of making and using same
#127Usage of odontogenic stem cells and genetically modified odontogenic stem cells
#128COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX
#129COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#130LYMPHANGIOGENESIS-PROMOTING AGENTS
#131Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor
#132GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE
#133Treatment of collagen defects using protein solutions
#134Dextran sulfate for use in mobilization of cells
#135Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides
#136METHODS OF TREATING SPINAL DISORDERS USING AUTOLOGOUS PROTEIN SOLUTIONS
#137Compositions and methods for cardiac tissue repair
#138Particles containing a growth factor, and uses thereof
#139Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
#140Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
#141Compositions and methods for treating and repairing tendons
#142Cancer cell trap
#143Urine stem cells for skeletal muscle generation and uses thereof
#144Generating hepatocytes
#145Methods of and devices for chemical and threshold-gated electrical neuro-immuno-stimulation that triggers the stem cell growth to restore bodily functions
#146Systems and methods for angiogenic treatment in wound healing
#147Bioactive compositions and methods for their preparation and use
#148THERAPEUTIC PLACENTAL COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE
#149Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
#150Gene therapy for diabetic neuropathy using an HGF isoform
#151Neuroprotection by hepatic cells and hepatocyte secretory factors
#152Preparations containing hepatocyte growth factor and hyaluronic acid and methods of making and using same
#153Acellular compositions for treating inflammatory disorders
#154Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof
#155ADHESIVE CELL TISSUE GELS
#156MULTIPLE GROWTH FACTOR COMPOSITIONS, METHODS OF FABRICATION, AND METHODS OF TREATMENT
#157Multi-Needle Injection Apparatus and System for Delivering Pharmacological Agents to Biological Tissue
#158Particles containing a growth factor, and uses thereof
#159Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
#160COMPOUNDS AND METHODS
#161Adeno-associated virus vector for gene transfer to nervous system cells
#162Composition and method for the inhibition of postoperative adhesions severity
#163Platelet-rich plasma compositions
#164Pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder
#165Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation
#166Peptide radiotracer compositions
#167Neuroprotection by hepatic cells and hepatocyte secretory factors
#168PHARMACEUTICAL COMPOSITION FOR PROMOTING ARTERIOGENESIS, AND PREPARATION METHOD AND APPLICATIONS FOR THE SAME
#169Monitoring and modulating HGF/HGFR activity
#170C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#171Regeneration and repair of neural tissue using postpartum-derived cells
#172Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof
#173DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS
#174ADHESIVE CELL TISSUE GELS
#175Methods for promoting the revascularization and reenervation of CNS lesions
#176Compositions And Methods For Cell Based Retinal Therapies
#177PARENTERAL COMPOSITION COMPRISING MICROSPHERES WITH A DIAMETER BETWEEN 10 AND 20 MICRONS
#178Drug carrier and drug carrier kit for inhibiting fibrosis
#179Compositions and methods for cardiac tissue repair
#180DRUG COMPOSITION FOR ANGIOGENESIS THERAPY
#181Fibrosis inhibitor for implanted organ
#182Drug carrier and drug carrier kit for inhibiting fibrosis
#183COMPOSITION OF INHIBITING PATHOLOGICAL ANGIOGENESIS
#184Therapeutic agent for spinal cord injuries
#185Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue
#186HEPATOCYTE GROWTH FACTOR PATHWAY ACTIVATORS IN DEMYELINATING DISEASES AND CENTRAL NERVOUS SYSTEM TRAUMA
#187Composition and method for the inhibition of postoperative adhesions severity
#188LYMPHANGIOGENESIS-PROMOTING AGENTS
#189Composition and periodical delivery system for cellular rejuvenation
#190Conditioned medium of liver progenitor cells
#191Methods for promoting the revascularization and reenervation of CNS lesions
#192GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE
#193METHODS AND COMPOSITIONS FOR TEMPORAL RELEASE OF AGENTS FROM A BIODEGRADABLE SCAFFOLD
#194SKIN ULCER PREVENTIVE CURATIVE AGENT CONTAINING HUMAN RECOMBINANT HGF
#195Regeneration and repair of neural tissue using postpartum-derived cells
#196Compositions and methods for angiogenic therapy utilizing genes encoding ets-1
#197MONITORING AND MODULATING HGF/HGFR ACTIVITY
#198Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#199Angiogenesis-modulating compositions and uses
#200Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof
#201Synergetic Effects of HGF and Antibacterial Treatment
#202Fibrosis inhibitor for implanted organ
#203Induction of Renal Cells for Treatment of Kidney Disease
#204THERAPEUTIC AGENT FOR SPINAL CORD INJURIES
#205MESOANGIOBLAST-LIKE CELL AS WELL AS METHODS AND USES RELATING THERETO
#206Repair of the Bone Marrow Vasculature
#207HGF preparation
#208Combination of CXCR4 Antagonist and Morphogen to Increase Angiogenesis
#209Componds and methods for pormoting angiogenesis
#210Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
#211DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR DISEASE ASSOCIATED WITH HEPATOCYTE GROWTH FACTOR RECEPTOR
#212Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof
#213Methods and compositions for the repair and/or regeneration of damaged myocardium
#214DRUG AND METHOD FOR IMPROVING BRAIN FUNCTION
#215Therapeutic angiogenesis for treatment of the spine
#216Methods for Inhibiting Carcinogenesis and/or Metastasis in an Individual with Endogenous C-Met Ligands and Inhibitors
#217CONDITIONED BLOOD COMPOSITION AND METHOD FOR ITS PRODUCTION
#218Antiviral Agent
#219Neovascularization Inhibitors Derived From HGF and Methods Involving the Same
#220CARDIOMYOPATHY THERAPEUTIC AGENT
#221Gene therapy for treatment of heart failure
#222MEDICAMENT COMPRISING HGF GENE
#223ISCHEMIA THERAPEUTIC AGENT
#224Porous objects having immobilized encapsulated biomolecules
#225C-Met receptor regulation by angiotensin IV (AT) receptor ligands
#226Fibrosis inhibitor for implanted organ
#227Gene therapy for diabetic ischemic disease
#228Treatment of Insulin Resistance and Diabetes
#229LOCALIZED MYOCARDIAL INJECTION METHOD FOR TREATING ISCHEMIC MYOCARDIUM
#230PREPARATIVE REGIMEN FOR ENGRAFTMENT, GROWTH AND DIFFERENTIATION OF NON-HEMATOPOEITIC CELLS IN VIVO AFTER TRANSPLANTATION
#231Agents for gene therapy of cerebrovascular disorders
#232Angiogenesis using hepatocyte growth factor
#233Hydrocephalus treatment
#234Drug carrier and drug carrier kit for inhibiting fibrosis
#235METHOD FOR FOSTERING BONE FORMATION AND PRESERVATION
#236Method for fostering bone formation and preservation
#237Method for fostering bone formation and preservation
#238METHOD FOR FOSTERING BONE FORMATION AND PRESERVATION
#239Agent for Prophylactic and/or Therapeutic Treatment of Retinopathy
#240Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
#241Method of Promoting Natural Bypass
#242Remedy for Alzheimer's Disease
#243C-Met receptor regulation by angiotensin IV (AT) receptor ligands
#244Method of treating skin ulcers with vectors encoding hepatocyte growth factor
#245Asthma preparation
#246Differentiation- or regeneration-inducing agent for alveoli
#247Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
#248Agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor
#249Needleless syringe having medical agent accomodated therein
#250Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#251Agent for improving mental disorders
#252Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#253Monitoring and modulating HGF/HGFR activity
#254Remedy for cardiomyopathy
#255Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#256Compounds and Methods for Promoting Angiogenesis
#257Therapeutic agent for preventing and/or treating sepsis
#258Method of reversing epithelial mesenchymal transition
#259Repair and regeneration of ocular tissue using postpartum-derived cells
#260Drug for auditory dysfunction
#261Lyophilized HGF preparations
#262Cell-containing preparations
#263Angiogenesis using hepatocyte growth factor
#264Skin ulcer preventive curative agent containing human recombinant hgf
#265Method of promoting natural bypass
#266Methods using TCF -II
#267Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
#268Remedy for ischemia
#269Methods for combating ischemic injury to epithelial organ
#270Cartilage and bone repair and regeneration using postpartum-derived cells
#271Method of differentiating umbilical cord tissue into a chondrogenic phenotype
#272Cartilage and bone repair and regeneration using postpartum-derived cells
#273Cartilage and bone repair and regeneration using postpartum-derived cells
#274Soft tissue repair and regeneration using postpartum-derived cells and cell products
#275Implantable medical devices comprising isolated extracellular matrix
#276Method for fostering bone formation and preservation
#277Agents for gene therapy of cerebrovascular disorders
#278Anti-cancer agent
#279Method for introducing a biological molecule using a viral envelope and heparin and system therefore
#280Method for fostering bone formation and preservation
#281Angiogenesis using hepatocyte growth factor
#282Medical composition containing photocrosslinkable chitosan derivative
#283Methods of enhancing stem cell engraftment
#284Postpartum cells derived from placental tissue, and methods of making and using the same
#285Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
#286Soft tissue repair and regeneration using postpartum-derived cells
#287Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same
#288Treatment of retinitis pigmentosa with human umbilical cord cells
#289Vascularization therapy by highly concentrated carbonated warm water bath
#290Regeneration and repair of neural tissue using postpartum-derived cells
#291Compositions and methods for treating fibrosis
#292Cartilage and bone repair and regeneration using postpartum-derived cells
#293Methods and compositions for treating vascular leak using hepatocyte growth factor
#294Processes for making and using a mesenchymal stem cell derived secretome